OPK
Price
$1.57
Change
+$0.08 (+5.37%)
Updated
Sep 11 closing price
Capitalization
1.17B
60 days until earnings call
Intraday BUY SELL Signals
UTMD
Price
$69.71
Change
+$0.07 (+0.10%)
Updated
Sep 11 closing price
Capitalization
221.99M
Intraday BUY SELL Signals
Interact to see
Advertisement

OPK vs UTMD

OPK vs UTMD Comparison Chart in %
View a ticker or compare two or three
VS
OPK vs. UTMD commentary
Sep 12, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is OPK is a Hold and UTMD is a Buy.

Interact to see
Advertisement
SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
OPK($1.17B) has a higher market cap than UTMD($222M). UTMD (25.755) and OPK (24.603) have similar YTD gains . OPK has higher annual earnings (EBITDA): 54.9M vs. UTMD (12.7M). OPK has more cash in the bank: 301M vs. UTMD (87.5M). UTMD has less debt than OPK: UTMD (195K) vs OPK (398M). OPK has higher revenues than UTMD: OPK (588M) vs UTMD (36.1M).
OPKUTMDOPK / UTMD
Capitalization1.17B222M528%
EBITDA54.9M12.7M432%
Gain YTD24.60325.75596%
P/E RatioN/A21.26-
Revenue588M36.1M1,629%
Total Cash301M87.5M344%
Total Debt398M195K204,103%
FUNDAMENTALS RATINGS
OPK vs UTMD: Fundamental Ratings
OPK
UTMD
OUTLOOK RATING
1..100
8683
VALUATION
overvalued / fair valued / undervalued
1..100
49
Fair valued
18
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9275
PRICE GROWTH RATING
1..100
4449
P/E GROWTH RATING
1..100
9821
SEASONALITY SCORE
1..100
5050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

UTMD's Valuation (18) in the Medical Specialties industry is in the same range as OPK (49) in the Biotechnology industry. This means that UTMD’s stock grew similarly to OPK’s over the last 12 months.

UTMD's Profit vs Risk Rating (100) in the Medical Specialties industry is in the same range as OPK (100) in the Biotechnology industry. This means that UTMD’s stock grew similarly to OPK’s over the last 12 months.

UTMD's SMR Rating (75) in the Medical Specialties industry is in the same range as OPK (92) in the Biotechnology industry. This means that UTMD’s stock grew similarly to OPK’s over the last 12 months.

OPK's Price Growth Rating (44) in the Biotechnology industry is in the same range as UTMD (49) in the Medical Specialties industry. This means that OPK’s stock grew similarly to UTMD’s over the last 12 months.

UTMD's P/E Growth Rating (21) in the Medical Specialties industry is significantly better than the same rating for OPK (98) in the Biotechnology industry. This means that UTMD’s stock grew significantly faster than OPK’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
OPKUTMD
RSI
ODDS (%)
Bearish Trend 1 day ago
83%
N/A
Stochastic
ODDS (%)
Bullish Trend 1 day ago
76%
Bullish Trend 1 day ago
64%
Momentum
ODDS (%)
Bullish Trend 1 day ago
74%
Bearish Trend 1 day ago
64%
MACD
ODDS (%)
Bearish Trend 1 day ago
80%
Bearish Trend 1 day ago
48%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
79%
Bearish Trend 1 day ago
50%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
74%
Bearish Trend 1 day ago
47%
Advances
ODDS (%)
Bullish Trend 11 days ago
74%
Bullish Trend 16 days ago
59%
Declines
ODDS (%)
Bearish Trend 3 days ago
81%
Bearish Trend 10 days ago
52%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
86%
Bullish Trend 1 day ago
74%
Aroon
ODDS (%)
Bullish Trend 1 day ago
79%
N/A
COMPARISON
Comparison
Sep 12, 2026
Stock price -- (OPK: $1.57 vs. UTMD: $69.71)
Brand notoriety: OPK and UTMD are both not notable
OPK represents the Medical Specialties, while UTMD is part of the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: OPK: 134% vs. UTMD: 26%
Market capitalization -- OPK: $1.17B vs. UTMD: $221.99M
OPK [@Medical Specialties] is valued at $1.17B. UTMD’s [@Pharmaceuticals: Other] market capitalization is $221.99M. The market cap for tickers in the [@Medical Specialties] industry ranges from $27 to $3.82T. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $126 to $130.41B. The average market capitalization across the [@Medical Specialties] industry is $18.5B. The average market capitalization across the [@Pharmaceuticals: Other] industry is $8.43B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

OPK’s FA Score shows that 0 FA rating(s) are green while UTMD’s FA Score has 2 green FA rating(s).

  • OPK’s FA Score: 0 green, 5 red.
  • UTMD’s FA Score: 2 green, 3 red.
According to our system of comparison, UTMD is a better buy in the long-term than OPK.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

OPK’s TA Score shows that 6 TA indicator(s) are bullish while UTMD’s TA Score has 3 bullish TA indicator(s).

  • OPK’s TA Score: 6 bullish, 4 bearish.
  • UTMD’s TA Score: 3 bullish, 4 bearish.
According to our system of comparison, OPK is a better buy in the short-term than UTMD.

Price Growth

OPK (@Medical Specialties) experienced а -4.27% price change this week, while UTMD (@Pharmaceuticals: Other) price change was -1.95% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was -3.54%. For the same industry, the average monthly price growth was +4.08%, and the average quarterly price growth was +36.27%.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was -3.51%. For the same industry, the average monthly price growth was -3.46%, and the average quarterly price growth was +12.67%.

Reported Earning Dates

OPK is expected to report earnings on Nov 11, 2026.

Industries' Descriptions

@Medical Specialties (-3.54% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

@Pharmaceuticals: Other (-3.51% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

View a ticker or compare two or three
OPK
Daily Signal:
Gain/Loss:
UTMD
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
CHCGX58.00N/A
N/A
Chesapeake Growth
DQIAX40.95N/A
N/A
BNY Mellon Equity Income Fund A
JAMCX33.53N/A
N/A
JPMorgan Mid Cap Value A
WISGX25.88N/A
N/A
Segall Bryant & Hamill Small Cap GrInstl
GLCPX34.68N/A
N/A
GuideMark® Large Cap Core RS

UTMD and

Correlation & Price change

A.I.dvisor indicates that over the last year, UTMD has been loosely correlated with CERS. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if UTMD jumps, then CERS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To UTMD
1D Price
Change %
UTMD100%
+0.10%
CERS - UTMD
50%
Loosely correlated
+1.22%
TMCI - UTMD
47%
Loosely correlated
+3.68%
INMD - UTMD
47%
Loosely correlated
+0.88%
ITGR - UTMD
44%
Loosely correlated
-0.04%
IART - UTMD
43%
Loosely correlated
-0.26%
More